Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Adalimumab helped control a child's severe eye disease when other treatments failed.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Ruby laser treatment is effective and well-tolerated for reducing hair growth.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

The FDA approved a new Pfizer drug for hair loss in teens.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Managing multiple autoimmune diseases in one patient is very challenging.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.